Registration Dossier

Administrative data

Key value for chemical safety assessment

Additional information

 

 

EC #

Avg MW

Ames test

Chromosomal aberration

451-070-8

525

negative

negative

451-120-9

537

negative

negative

451-190-0

544

negative

Read-across

453-150-8

554

negative

Read-across

451-200-3

585

negative

Read-across

430-320-1

611

negative

negative

451-110-4

613

negative

Read-across

451-400-0

637

negative

negative

451-220-2

648

negative

Read-across

451-180-6

652

negative

Read-across

452-180-9

657

negative

Read-across

453-470-8

783

negative

Read-across

452-270-8

883

negative

Read-across

453-480-2

1012

negative

Read-across

444-000-2

1023

negative

negative

453-450-9

1036

negative

Read-across

453-490-7

1066

negative

Read-across

453-460-3

1094

negative

Read-across

HXL-8366 (700 -325 -4)

878

Read-across:

negative

Read-across:

negative

 


Short description of key information:
Conclusions for HXL-8366 are based on read across from analogue substances of a known category. See also Report 491517_Read-across approach for REACH registration of HXL-8366 , attached under 1. General information

Endpoint Conclusion: No adverse effect observed (negative)

Justification for classification or non-classification

Based on the information above mentioned 'discussion' the substance is not classified for mutagenicity.